Uzbekistan scientists build national genome database to predict diabetes and heart disease risk
Published: · Русский · O‘zbekcha
Tashkent's Center for Advanced Technologies has launched the '1000 Genomes of Uzbekistan' project to build genetic risk models for type 2 diabetes and ischemic heart disease.

The molecular genetics laboratory at Tashkent's Center for Advanced Technologies (CaT) launched the '1000 Genomes of Uzbekistan' project in summer 2026. By early November, over 500 blood samples had been collected in Tashkent and Karakalpakstan; collection is ongoing in the Fergana Valley, with Khorezm, Bukhara, and Samarkand regions planned next. The first 1,000 genomes are expected to be sequenced by 2028. The Ministry of Health is involved in the effort.
Participation is voluntary. Young people attending mandatory pre-marriage medical check-ups complete a 60-question questionnaire on health, habits, and lifestyle, then provide a blood sample. Personal data is stored in Uzbekistan and shared with other organisations only with the participant's consent.
According to lab director Alisher Abdullaev, many existing genetic tests and risk models were built on European and North American data, which may not apply equally well to Uzbek residents. The national database will enable polygenic risk scores — combining multiple genetic variants rather than a single mutation — to assess predisposition to type 2 diabetes and ischemic heart disease. A genetic predisposition does not guarantee disease; it is evaluated alongside lifestyle and clinical data.
The CaT is also developing a DNA chip for affordable carrier screening of recessive genetic conditions.
Source: Gazeta.uz (Фарзона Хамидова, 10.11.2026) · Read the original source ↗
Share this news




